| | |

Patients Live Twice as Long with Less of this Biomarker for Pleural Mesothelioma

biomarker for pleural mesotheliomaAn enzyme that helps mop up the products of cellular oxidation might also serve as a powerful biomarker for pleural mesothelioma. People with the lowest levels of this enzyme  survived longer with mesothelioma than those with higher levels.

Glutathione peroxidase-1 (GPX-1) is an enzyme found in all cells. It helps keep toxins from building up inside cells. It also helps regulate certain cellular processes.  

But there is also evidence that GPX-1 may play a role in the development of cancer. Researchers in Egypt recently discovered that pleural mesothelioma tumors have more GPX-1 than the healthy tissue around them. The less they have, the better the prognosis. 

The findings suggest that GPX-1 could be a useful biomarker for pleural mesothelioma. 

Mesothelioma Diagnosis and Prognosis

Pleural mesothelioma is a cancer in the tissue surrounding the lungs. Survival is historically dismal. One reason is that it is difficult to diagnose mesothelioma. By the time most people know they have it, it may be too late for effective treatment. 

Having a reliable biomarker for pleural mesothelioma could change those odds. A biomarker is something in the cells, tissue, or body fluid of someone with an illness that is either not found in healthy people or is found at a different level. 

If doctors know that mesothelioma patients produce more or less of a particular substance, mesothelioma diagnosis can be easier, faster, and more reliable.

A biomarker for pleural mesothelioma can also help with prognosis. If levels of a certain substance go up or down in relation to the death of cancer cells, doctors can measure that substance to gauge how well a treatment works.

GPX-1 as a Biomarker for Pleural Mesothelioma

All cells contain some amount of GPX-1. It is an antioxidant enzyme. Hydrogen peroxide is one product of cellular oxidation. It influences some cellular processes. But it is also toxic at high levels. GPX-1 turns hydrogen peroxide into harmless water. 

Previous studies show GPX-1 may play a role in cancer development. Researchers at Egypt’s Zagazig University Hospital checked GPX-1 levels in mesothelioma cells and patients. The goal was to see whether it could be helpful as a biomarker for pleural mesothelioma. 

In the lab, researchers discovered that mesothelioma cells had higher GPX-1 levels than the surrounding pleural tissue. “It was found to be of important diagnostic specificity in the differentiation of MPM from normal tissues,” reports researcher Amal Gharib.

They also assessed GPX-1 as a potential biomarker in pleural mesothelioma patients. They included 98 Zagazig Hospital mesothelioma surgery patients in the analysis. Patients with the lowest GPX-1 levels lived twice as long as those with high expression. 

“Median overall survival was about 16 months in patients with high GPX1 expression levels, while it was found to be about 40 months in low GPX1 levels,” states the report in the Swiss medical journal, Diagnostics. 

Some of the other potential biomarkers for pleural mesothelioma include:

Combining biomarkers can improve the accuracy of testing for mesothelioma. 

Source:

Gharib, A, et al, “Assessment of Glutathione Peroxidase-1 (GPX1) Gene Expression as a Specific Diagnostic and Prognostic Biomarker in Malignant Pleural Mesothelioma”, December 7, 2021, Diagnostics, Volume 11, Issue 12,  https://www.mdpi.com/2075-4418/11/12/2285

 

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…